IABP-SHOCK II Risk Score Calculator
Risk assessment
Enter admission variables and final TIMI flow grade after PCI. Intended for risk stratification in AMI-related cardiogenic shock.
About the IABP-SHOCK II Risk Score
This score was developed to stratify 30-day mortality risk among patients with cardiogenic shock complicating acute myocardial infarction (AMI-CS). Six clinical, laboratory, and post-PCI variables are included. It is not a substitute for clinical assessment or a stand-alone treatment-selection rule.
Variables and points
| Variable | Criterion | Points |
|---|---|---|
| Age | >73 years | 1 |
| Prior stroke | History of stroke | 2 |
| Admission glucose | >191 mg/dL | 1 |
| Admission creatinine | >1.5 mg/dL | 1 |
| Admission arterial lactate | >5 mmol/L | 2 |
| Post-PCI TIMI flow | Grade <3 | 2 |
Risk categories in the derivation cohort
| Total score | Category | Observed 30-day mortality |
|---|---|---|
| 0–2 | Low | 23.8% |
| 3–4 | Intermediate | 49.2% |
| 5–9 | High | 76.6% |
Clinical context and limitations
The original score was derived in patients with infarct-related cardiogenic shock in the IABP-SHOCK II trial setting. Discrimination and absolute mortality rates may differ by population and care setting. The post-PCI TIMI variable is intended for patients who underwent PCI and have a documented final flow grade.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.